Paragon Biosciences is a business involved in the science of innovative life. The company assists other companies by investing in the production of biotechnology developments which improves the health care given to patients. The corporations which are managed by Paragon Sciences focuses on discovering solutions for patients who are suffering from incapacitating ailments that as of the present has no form of effective medical treatment.
To make everything efficient, Paragon Biosciences integrates three procedures of workflow which are to identify, to build and to develop. By implementing this work method, Paragon Biosciences will be able to recognize the best answer to address the patient’s needs. So far, the team at Paragon was efficiently able to obtain 13 Novel Drug Approvals from the Food and Drug Administration.
Jeff Aronin is the chairman and chief executive officer of Paragon Biosciences who likewise established Paragon Pharmaceutical LLC that provides support for the Paragon portfolio companies.
Jeff’s fascination with pharmaceutical technology started when he was shadowing a doctor that was treating a patient with epilepsy (Thenewsversion). The said doctor had a common option at that time which was to operate on the patient and take out a part of the brain. However, instead of doing it the traditional way, the doctor chose to find another method on how to handle the patient’s seizures by administering a dosage of medicine that lessened the epileptic seizures successfully.
After having witnessed what transpired, Jeff Aronin realized that the doctor took another route that is less debilitating to the patient and this particular scenario was what encouraged him to actively invest in the biopharmaceutical industry.
Jeff Aronin finished his Bachelor of Science Degree from the University of Northern Illinois and earned his Master’s in Business Administration from DePaul University. He is also an Aspen Institute Henry Crown Fellow.
Besides overseeing Paragon Pharmaceutical and Paragon Biosciences, Jeff Aronin provides lectures at the Chicago Booth Schools of Business University and the Kellogg School of Management at the Northwestern University. He is also the Co-chairman of MATTER and a member of the World Business Chicago Board of Directors.